Revagenix exists to deliver urgently needed anti-infective medicines to patients around the world. To accomplish this, we design our therapeutic profiles and business strategy through a holistic understanding of the needs, opportunities, and challenges at each stage of the biopharmaceutical lifecycle, from research, to development, to commercialization.
Our mission at Revagenix is to create life-changing antibiotics. We're passionate about moving the needle on the tens of thousands of deaths every year due to drug-resistant infections.
Revagenix is advancing a proprietary pipeline of highly differentiated antibiotic programs in late preclinical stage, each with game-changing potential.
